Sort
59,101 grants matching “hypertension”
Modifiable cardiovascular factors linking type 2 diabetes and Alzheimer's disease
$782,563Antonio Convit · New York University School Of Medicine · R01 · FY2022 · AG
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
$782,512Maria Mori Brooks · University Of Pittsburgh At Pittsburgh · U24 · FY2022 · HL
Improving understanding of sleep apnea pathogenesis using novel imaging techniques during sleep
$782,473Richard J. Schwab · University Of Pennsylvania · R01 · FY2025 · HL
Multilevel Determinants of Circadian Factors and Sleep Disruption: Implications for Cardiometabolic Health Among African-Americans
$782,268Dayna Johnson · Emory University · R01 · FY2025 · HL
JUSTice-Involved Individuals Cardiovascular Disease Epidemiology (JUSTICE)
$782,228Emily Ai-Hua Wang · Yale University · R01 · FY2019 · HL
Changing the Default for Tobacco Treatment
$782,173Kimber P Richter · University Of Kansas Medical Center · R01 · FY2016 · HL
PTSD, Sleep, and Risk for Incident Hypertension
$782,145Matthew M. Burg · Yale University · R01 · FY2018 · HL
Examining Obesity Declines Among School Children: The Role of Changes in the Food and Physical Activity Environments
$782,027Michael Joel Yedidia · Rutgers, The State Univ Of N.J. · R01 · FY2017 · HL
Development and validation of a novel 3D human in vitro model of nonalcoholic steatohepatitis to be used for novel therapeutic screening and research on disease mechanism.
$782,018Alice Chen · Organovo, Inc. · R44 · FY2018 · DK
Sub Clinical Cardiovascular Disease in Youth (SEARCH CVD)
$782,003Dana Dabelea · University Of Colorado Denver · R01 · FY2009 · DK
The emerging role of apelin, RAAS, and ACE2 crosstalk in pulmonary hypertension
$781,934Andrea Lee Frump · Indiana University Indianapolis · R01 · FY2025 · HL
Technology Innovations for Supporting Health in Alaska Native People
$781,927Judith J. Prochaska · Stanford University · R01 · FY2015 · HL
Basic Cardiovascular Research Training Grant
$781,886Gary K Owens · University Of Virginia · T32 · FY2013 · HL
Elucidating novel mechanisms for glucocorticoid-induced ocular hypertension
$781,864Lucia Sobrin · Massachusetts Eye And Ear Infirmary · R01 · FY2022 · EY
Heart-Related Multiple Chronic Conditions in Primary Care: Behavioral Technology
$781,663David H Gustafson · University Of Wisconsin-Madison · R01 · FY2017 · HL
Ventricular-vascular coupling in the elderly: lifecourse determinants, trajectories and prognostic significance
$781,656Vasan S. Ramachandran · Boston University Medical Campus · R01 · FY2021 · HL
A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
$781,650Douglas F Zatzick · University Of Washington · UH2 · FY2014 · MH
Mechanisms of newborn pulmonary hypertension caused by chronic intrauterine hypoxia
$781,572Arlin B Blood · Loma Linda University · R01 · FY2023 · HL
Racial Differences in Atherosclerosis, Plaque Vulnerability, and CVD
$781,510Steven E Reis · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · HL
Sodium Regulation in Individuals on Known Dietary Sodium Intake
$781,466Cheryl Ann Marie Anderson · University Of California, San Diego · R01 · FY2018 · HL
Disrupted Sleep in Somali Americans â Implications for Hypertension Risk
$781,437Virend K Somers · Mayo Clinic Rochester · R01 · FY2023 · HL
ApoE2 and protective molecular signatures in Alzheimer's disease and aging
$781,190Alexander M Kulminski · Duke University · R01 · FY2018 · AG
Gut microbiome-related metabolites and cognitive impairment
$781,115William Taylor Kimberly · Massachusetts General Hospital · R01 · FY2025 · AG
Genetic and Non-Genetic Modulators of Morbidity/Disability Compression in a Large Population-Based Study of Cognitive and Physical Impairment with Emphasis on Alzheimer's Disease and Related Dementias
$781,094P.j. Eric Stallard · Duke University · R01 · FY2021 · AG
Stress Management and Biomarkers of Risk in Cardiac Rehabilitation
$781,019James A. Blumenthal · Duke University · R01 · FY2009 · HL